Survival analysis of SATB1-AS1 in cancers other than THYM revealed that SATB1-AS1 also had a significant effect on survival in BLCA, KIRC, Acute Myeloid Leukemia (LAML), Lower Grade Glioma (LGG), Lung Adenocarcinoma (LUAD), Sarcoma (SARC), SKCM and Ocular melanomas (UVM) (P < 0.05, Fig 6B). Here, SATB1 is linked to sarcoma.